Sa1430 - Effect of Vedolizumab, Infliximab, and Adalimumab on Biliary Inflammation in Individuals with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Volume: 154, Issue: 6, Pages: S - 303
Published: May 1, 2018
Abstract
No abstract.
Paper Details
Title
Sa1430 - Effect of Vedolizumab, Infliximab, and Adalimumab on Biliary Inflammation in Individuals with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Published Date
May 1, 2018
Volume
154
Issue
6
Pages
S - 303
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.